GI Issues
Symptom management for well-differentiated gastroenteropancreatic neuroendocrine tumors: ASCO guideline.
JCO Oncol Pract 2025; DOI https//doi.org/10.1200/OP-25-00133
Efficacy of cannabinoids for the prophylaxis of chemotherapy-induced nausea and vomiting—a systematic review and meta-analysis.
Support Care Cancer 2025;33:193
Effective RX for CINV and MBO: Do we really need so many drugs?
Effect of adding electro-acupuncture to standard triple anti-emetic therapy on chemotherapy-induced nausea and vomiting: a randomized controlled clinical trial.
J Clin Oncol 2024;42:4051-4059.
Methylene blue for the treatment of intractable pain from oral mucositis related to cancer treatment: an uncontrolled cohort.
JNCCN 2021; 19:521-527.
Cancer cachexia: ASCO guideline rapid recommendation update.
The ASCO panel confirmed that there are NO FDA-approved medications to treat cancer cachexia, including olanzapine and mirtazapine.
Streptococcus salivarius K12 alleviates oral mucositis in patients undergoing radiotherapy for malignant head and neck tumors: a randomized controlled trial.
J Clin Oncol 2024;42. Online article.
MASCC/ISOO Expert Opinion on the Management of Oral Problems in Patients with Advanced Cancer
Support Care Cancer 2022; 30:8761-8773
Dr. Abrahm's Book
Dr. Abrahm is the author of four comprehensive editions on supportive and palliative care for patients with cancer, the first published in 2000 and the latest in 2022.
Her extensive work offers oncologists and other oncology and palliative care clinicians a place to turn to find the most up-to-date evidence-based practices, resources, and practical advice on how to care for patients across the full range of issues they will experience during their illness.
Comments from Dr. Abrahm:
Patients can get SsK12 (streptococcus salivarius K12) lozenges from NOW foods, USA. During XRT, they took them tid and avoided any oral intake for at least an hour.